1304 related articles for article (PubMed ID: 9557929)
1. A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women.
Straznicky NE; Barrington VE; Branley P; Louis WJ
J Hypertens; 1998 Mar; 16(3):357-68. PubMed ID: 9557929
[TBL] [Abstract][Full Text] [Related]
2. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Godsland IF; Crook D; Devenport M; Wynn V
Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
[TBL] [Abstract][Full Text] [Related]
3. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives.
Sheu WH; Hsu CH; Chen YS; Jeng CY; Fuh MM
Clin Endocrinol (Oxf); 1994 Feb; 40(2):249-55. PubMed ID: 8137525
[TBL] [Abstract][Full Text] [Related]
5. The short-term effects of a low-dose oral contraceptive on glucose metabolism, plasma lipids and blood clotting factors.
Skouby SO; Wagner HH; Andersen O
Contraception; 1983 Nov; 28(5):489-99. PubMed ID: 6425010
[TBL] [Abstract][Full Text] [Related]
6. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.
Fioretti P; Fruzzetti F; Navalesi R; Ricci C; Miccoli R; Cerri M; Orlandi MC; Melis GB
Contraception; 1987 Mar; 35(3):229-43. PubMed ID: 2956055
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoking and oral contraceptive use influence women's lipid, lipoprotein, and cardiovascular responses during stress.
Davis MC; Matthews KA
Health Psychol; 1990; 9(6):717-36. PubMed ID: 2286182
[TBL] [Abstract][Full Text] [Related]
8. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of the combined oral contraceptive pill on carbohydrate and lipid metabolism in Singapore women--a cross-sectional study.
Ng CS; Chng JW; Oakley NW; Wynn V; Ratnam SS
Ann Acad Med Singap; 1982 Oct; 11(4):567-74. PubMed ID: 6762138
[TBL] [Abstract][Full Text] [Related]
10. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
Oyelola OO
Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
[TBL] [Abstract][Full Text] [Related]
12. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
13. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate tolerance and serum lipid responses to type of dietary carbohydrate and oral contraceptive use in young women.
Moser PB; Behall KM; Kelsay JL; Prather ES
J Am Coll Nutr; 1986; 5(1):45-53. PubMed ID: 3517111
[TBL] [Abstract][Full Text] [Related]
15. Interaction of oral contraceptive use with the effects of age, exercise habits and other cardiovascular risk modifiers on metabolic risk markers.
Godsland IF
Contraception; 1996 Jan; 53(1):9-16. PubMed ID: 8631192
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure rhythm and endocrine functions in normotensive women on oral contraceptives.
Heintz B; Schmauder C; Witte K; Breuer I; Baltzer K; Sieberth HG; Lemmer B
J Hypertens; 1996 Mar; 14(3):333-9. PubMed ID: 8723987
[TBL] [Abstract][Full Text] [Related]
17. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women. III. Serum glucose, insulin, and glucagon.
Behall KM; Moser PB; Kelsay JL; Prather ES
Am J Clin Nutr; 1980 May; 33(5):1041-8. PubMed ID: 6989226
[TBL] [Abstract][Full Text] [Related]
18. The effects of two triphasic oral contraceptives on carbohydrate metabolism in women during 1 year of use.
Spellacy WN; Ellingson AB; Tsibris JC
Fertil Steril; 1989 Jan; 51(1):71-4. PubMed ID: 2642814
[TBL] [Abstract][Full Text] [Related]
19. Changes in insulin receptors during oral contraception.
De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R
J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate metabolism of Indian women taking steroid contraceptives.
Barsivala VM; Virkar K; Kulkarni RD
Fertil Steril; 1976 Jan; 27(1):87-91. PubMed ID: 1245247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
